US4327710A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Process for encapsulating additives in resealed erythrocytes for disseminating chemicals via the circulatory system
Assignee: United States Department of Agriculture
•
Filing: 1980-06-18
•
Granted: 1982-05-04
•
Expires: 2000-06-18
Abstract
Abstract An apparatus and a process for encapsulating additives in resealed erythrocytes from the blood of certain mammals. The invention provides a means of preparing material in substantial quantities, to be employed as vaccine which, when reinjected into these mammals, provides a systemic protection against blood-sucking insects or other parasites.
Inventors
- 👤 John R. DeLoach
- 👤 Robert L. Harris
- 👤 Garret M. Ihler
- 👤 Richard T. Mayer
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 08:57
CPC Classifications
A; A61; A61D; A61D7/00; A61K; A61K35/00; A61K35/12; A61K35/14; A61K35/18; A61K9/00; A61K9/48; A61K9/50; A61K9/5005; A61K9/5063; A61K9/5068
Claims Analysis
Total Claims: 19
Claim 1
Independent Claim
233 words
A process for encapsulating additives in resealed erythrocytes of the blood of certain animals to provide a means of disseminating additives via the circulatory system of said animals, the process comprising: (a) withdrawing whole blood from a live animal, (b) separating the erythrocytes from the serum and the other cells, (c) placing the erythrocytes in a dialysis membrane containing an isotonic solution of sodium chloride, said membrane being filled to no more than 75% of its volume, (d) inflating the remaining volume of the membrane with air, (e) placing the charged dialysis membrane under hypotonic solution, (f) rotating the charged membrane under hypotonic solution for about from 30 to 60 minutes, thus causing a swelling of the erythrocytes until pores appear in the erythrocyte membrane, allowing intracellular and extracellular contents to equilibrate across the erythrocyte membrane, (g) removing the erythrocyte solution from the membrane and mixing with a hypotonic solution containing an additive, (h) rotating the re-charged membrane under isotonic solution for about 60 minutes, thus causing through the adjustment of osmolality the annealing of the erythrocyte cell membrane, to yield an additive which is encapsulated within resealed erythrocytes, (i) placing the resealed erythrocytes in an isotonic solution and separating the resealed erythrocytes from the unencapsulated additive, and (j) injecting the isotonic solution of resealed erythrocytes into the circulatory system of the same species of animal from whence the whole blood was withdrawn.
Claim 2
Dependent Claim
233 words
A process for encapsulating additives in resealed erythrocytes of the blood of certain animals to provide a means of disseminating additives via the circulatory system of said animals, the process comprising: (a) withdrawing whole blood from a live animal, (b) separating the erythrocytes from the serum and the other cells, (c) placing the erythrocytes in a dialysis membrane containing an isotonic solution of sodium chloride, said membrane being filled to no more than 75% of its volume, (d) inflating the remaining volume of the membrane with air, (e) placing the charged dialysis membrane under hypotonic solution, (f) rotating the charged membrane under hypotonic solution for about from 30 to 60 minutes, thus causing a swelling of the erythrocytes until pores appear in the erythrocyte membrane, allowing intracellular and extracellular contents to equilibrate across the erythrocyte membrane, (g) removing the erythrocyte solution from the membrane and mixing with a hypotonic solution containing an additive, (h) rotating the re-charged membrane under isotonic solution for about 60 minutes, thus causing through the adjustment of osmolality the annealing of the erythrocyte cell membrane, to yield an additive which is encapsulated within resealed erythrocytes, (i) placing the resealed erythrocytes in an isotonic solution and separating the resealed erythrocytes from the unencapsulated additive, and (j) injecting the isotonic solution of resealed erythrocytes into the circulatory system of the same species of animal from whence the whole blood was withdrawn.
Claim 3
Dependent Claim
20 words
The process of claim 1 wherein the live animal is selected from the group consisting of cows, horses, and pigs.
Claim 4
Dependent Claim
22 words
The process of claim 1 wherein the rate of dialysis is predictable and reproducible, and follows first order kinetics for 60 minutes.
Claim 5
Dependent Claim
24 words
The process of claim 1 wherein the time required for dialyzing the erythrocytes until pores open in their membrane is less than 30 minutes.
Claim 6
Dependent Claim
22 words
The process of claim 1 wherein volumes of erythrocytes up to about 200 milliters can be dialyzed in less than 45 minutes.
Claim 7
Dependent Claim
18 words
The process of claim 1 wherein the dialyzing apparatus is self contained and requires no external temperature modulation.
Claim 8
Dependent Claim
21 words
The process of claim 1 wherein the temperature of the dialyzing medium can be varied from about 0.5° to 45° C.
Claim 9
Dependent Claim
18 words
The process of claim 1 wherein the specimen rotation is about from 5 to 15 revolutions per minute.
Claim 10
Dependent Claim
36 words
The process of claim 1 wherein the concentration of the additive is limited to a maximum, said maximum being a quantity which when mixed with the dialyzed erythrocytes said quantity does not appreciably increase the osmolality.
Claim 11
Dependent Claim
20 words
The process of claim 1 wherein the additive is selected from the group consisting of pesticides, enzymes, and certain drugs.
Claim 12
Dependent Claim
14 words
The process of claim 1 wherein the whole blood is bovine, equine, or porcine.
Claim 13
Dependent Claim
22 words
The process of claim 1 wherein the dialysis membrane is one which retains molecules of greater than 12,000 to 14,000 molecular weight.
Claim 14
Dependent Claim
19 words
The process of claim 1 wherein the additive is selected from the group consisting of dimilin, sucrose and B-galactosidase.
Claim 15
Dependent Claim
16 words
The process of claim 1 wherein the blood of equine is dialyzed at about 24° C.
Claim 16
Dependent Claim
19 words
The process of claim 1 wherein the blood of porcine is dialyzed at about from 0.5° to 5° C.
Claim 17
Dependent Claim
19 words
The process of claim 1 wherein the blood of bovine is dialyzed at about from 0.5° to 5° C.
Claim 18
Dependent Claim
23 words
The process of claim 1 wherein about 30% of an additive is encapsulated in the resealed erythrocytes from equine, bovine, or porcine blood.
Claim 19
Dependent Claim
14 words
The process of claim 1 wherein the erythrocytes are annealed at about 37° C.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1985-05-03 | 1985-11-02 | 1986-05-04 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1989-05-03 | 1989-11-02 | 1990-05-04 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1993-05-03 | 1993-11-02 | 1994-05-04 | $7700.00 | Window Closed / Lapsed |